P21 Adherence to pharmacological treatment in patients with diabetes mellitus type 2 and high cardiovascular risk

Abstract

Introduction: The treatment of chronic non-communicable diseases, including type 2 diabetes mellitus (DM2), generally requires changes in lifestyle and pharmacological measures. Lack of adherence is a frequent problem around de world, ranging between 30 to 50% in different studies. Non-adherent patients have a higher incidence of cardiovascular events and higher mortality compared to adherent patients. Therefore, it increases costs in the health systems. Objective: Analyze the adherence to pharmacological treatment indicated in a group of patients with DM2 and high cardiovascular risk. Assess the differences in clinical characteristics and scopes of therapeutic goals in the adherent population in comparison with non-adherent patients. Study design and methods: We carried out an observational, cross-sectional and multicenter study. Patients with DM2 that assisted to the cardiology office from May to July 2019, were consecutively registered. From the total p with DM2, we included in the registry, the first two p of each day. Adherence was assessed using the Morisky-Green test, which consists of 4 questions with two possible answers options: YES/NO. We defined adherence when the 4 answers were affirmative. We consider a non-adherent patient when presenting 1 or more negative answers. Therapeutic goals were defined: blood pressure under 140/90 mmHg, 2) HbA1c < 7% and 3) LDL cholesterol < 100 in patients without Cardiovascular disease (CVD) and < 70 mg/dl in patients with CVD. 4) triple goal: points 1,2 and 3 within the corresponding values.

Keywords

• tratamiento farmacológico
• diabetes tipo 2
• riesgo cardiovascular